|
Q1 2018
Filed on May 14, 2018
|
1,000
|
$38.4 - $42.8
$38.4K - $42.8K
|
|
|
Q1 2018
Filed on May 14, 2018
|
170
|
N/A
|
|
United States Treas Bills Bill
|
Q1 2018
Filed on May 14, 2018
|
850
|
N/A
|
|
|
Q1 2018
Filed on May 14, 2018
|
1,497
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
281
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
35
|
$2.66 - $3.71
$93.1 - $130
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
335
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
3,496
|
$3.61 - $6.25
$12.6K - $21.9K
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
1,967
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
205
|
$51.87 - $58.77
$10.6K - $12K
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
3,029
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
500
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
500
|
$34.05 - $37.9
$17K - $19K
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
22
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
7,940
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
200
|
$40.47 - $47.58
$8.09K - $9.52K
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
300
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
750
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
50
|
N/A
|
|
Energy Transfer Partners LP
|
Q4 2017
Filed on Jan 31, 2018
|
819
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
218
|
$6.35 - $7.9
$1.38K - $1.72K
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
100
|
$71.05 - $77.45
$7.11K - $7.75K
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
1,000
|
N/A
|
|
Invivo Therapeutics Hldgs CO
|
Q4 2017
Filed on Jan 31, 2018
|
9,411
|
N/A
|
|
Jp Morgan Chase & CO Senior Note
|
Q4 2017
Filed on Jan 31, 2018
|
50
|
N/A
|
|
Jp Morgan Chase & CO Senior Note
|
Q4 2017
Filed on Jan 31, 2018
|
50
|
N/A
|
|
J P Morgan Exchange Traded F
|
Q4 2017
Filed on Jan 31, 2018
|
78
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
50
|
$14.39 - $16.73
$720 - $837
|
|
Level 3 Communications Inc $26.50/Sh & 1.4286:1 Exc
|
Q4 2017
Filed on Jan 31, 2018
|
156
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
1,000
|
$22.85 - $36.57
$22.9K - $36.6K
|
|
Quantenna Communications Inc
|
Q4 2017
Filed on Jan 31, 2018
|
196
|
N/A
|
|
Repros Therapeutics Inc Com
|
Q4 2017
Filed on Jan 31, 2018
|
16,400
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
80
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
3,655
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
23
|
N/A
|
|
Twenty First Centy Fox Inc
|
Q4 2017
Filed on Jan 31, 2018
|
2,715
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
72
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
333
|
$25.13 - $27.21
$8.37K - $9.06K
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
411
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
1,000
|
N/A
|
|
Claymore Exchange Trd Fd Tr
|
Q4 2017
Filed on Jan 31, 2018
|
1,855
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
1
|
$74.8 - $87.74
$74.8 - $87.7
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
805
|
$39.46 - $46.76
$31.8K - $37.6K
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
35
|
$85.78 - $96.96
$3K - $3.39K
|
|
Peregrine Pharmaceuticals In
|
Q4 2017
Filed on Jan 31, 2018
|
1,401
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
100
|
N/A
|
|
Second Sight Med Prods Inc
|
Q4 2017
Filed on Jan 31, 2018
|
2,638
|
N/A
|
|
|
Q4 2017
Filed on Jan 31, 2018
|
6,274
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
672
|
$9.27 - $12.3
$6.23K - $8.27K
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
310
|
N/A
|
|